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Abstract 
Ca2+ signaling pathways are well studied in cardiac myocytes, but not in cardiac fibroblasts. The aim of 
the present study is to characterize Ca2+ signaling pathways in cultured human cardiac fibroblasts 
using confocal scanning microscope and RT-PCR techniques. It was found that spontaneous 
intracellular Ca2+ (Ca2+i) oscillations were present in about 29% of human cardiac fibroblasts, and the 
number of cells with Ca2+i oscillations was increased to 57.3% by application of 3% fetal bovine serum. 
Ca2+i oscillations were dependent on Ca2+ entry. Ca2+i oscillations were abolished by the 
store-operated Ca2+ (SOC) entry channel blocker La3+, the phospholipase C inhibitor U-73122, and the 
inositol trisphosphate receptors (IP3Rs) inhibitor 2-aminoethoxydiphenyl borate, but not by ryanodine. 
The IP3R agonist thimerosal enhanced Ca2+i oscillations. Inhibition of plasma membrane Ca2+ pump 
(PMCA) and Na+-Ca2+ exchanger (NCX) also suppressed Ca2+i oscillations. In addition, the frequency 
of Ca2+i oscillations was reduced by nifedipine, and increased by Bay K8644 in cells with spontaneous 
Ca2+ oscillations. RT-PCR revealed that mRNAs for IP3R1-3, SERCA1-3, CaV1.2, NCX3, PMCA1,3,4, 
TRPC1,3,4,6, STIM1, and Orai1-3, were readily detectable, but not RyRs. Our results demonstrate for 
the first time that spontaneous Ca2+i oscillations are present in cultured human cardiac fibroblasts and 
are regulated by multiple Ca2+ pathways, which are not identical to those of the well studied contractile 
cardiomyocytes. This study provides a base for future investigations into how Ca2+ signals regulate 
biological activity in human cardiac fibroblasts and cardiac remodeling under pathological conditions. 
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Introduction 
 Cardiac fibroblasts account for more than 50% of cells in heart, surrounding myocytes and 
bridge ‘the voids’ between myocardial tissue layers. Under normal circumstances, cardiac 
fibroblasts are believed to play an important role: in the maintenance of myocardial structure 
including extracellular matrix homeostasis and the production of growth factors, cytokines, 
and matrix metalloproteinases (Baudino et al, 2006). However, during cardiovascular disease, 
cardiac fibroblasts play a crucial role in myocardial remodeling, including cardiomyocyte 
hypertrophy, migration and proliferation of fibroblasts, and alterations in deposition and 
composition of the extracellular matrix. Excessive proliferation and increase in extracellular 
matrix protein result in fibrosis: subsequent myocardial stiffening that can lead to cardiac 
dysfunction (Brown et al, 2005;Manabe et al, 2002;Weber and Brilla, 1991). However, the 
cellular biology and physiology of human cardiac fibroblasts are not fully understood.  
 The cytosolic free calcium ion (Ca2+i) functions as a highly versatile second messenger in 
virtually all types of eukaryotic cells. Ca2+i regulates a wide range of cell functions including 
excitation-contraction coupling, excitation-secretion coupling, gene transcription, cell growth, 
differentiation, apoptosis, membrane fusion, and ion channel activation (Berridge et al, 2000).  
In most eukaryotic cells, Ca2+ is released from the internal store and initiates Ca2+ entry across 
plasma membrane (Berridge et al, 2000). In addition, Ca2+ extrusion systems maintain a 
nanomolar level of Ca2+i concentration (Herchuelz et al, 2002;Strehler et al, 2007). However, 
Ca2+ signals in cardiac fibroblasts are not as well studied as those as in cardiac myocytes (Bers 
and Guo, 2005;Grueter et al, 2007;Wang et al, 2004). Little information is available in the 
literature about the Ca2+ signaling pathways in human cardiac fibroblasts; the present study 
was therefore to characterize Ca2+ signaling pathways in cultured human cardiac fibroblasts. 
Material and methods 
Cell cultures 
  Human cardiac fibroblasts (adult ventrical, Catalog# 6310) were purchased from 
ScienCell Research Laboratory (San Diego, CA). The cells were cultured as monolayers in 
completed DMEM containing 10% fetal bovine serum (Invitrogen, Hong Kong) and antibiotics 
(100 U/ml penicillin G and 100 μg/ml streptomycin) at 37°C in a humidified atmosphere of 
95% air, 5% CO2. Cells used in this study were from the early passages 2 to 6 to limit the 
possible variations in Ca2+ signals and gene expression (Li et al, 2009).  
Ca2+i measurements  
 The cells were loaded with 5 µM fluo-3 AM (Biotium Inc., CA) for 30 min at 37°C and 
incubated in physiological bath solution for 30 min. The bath solution contained (in mM): 
NaCl 140, NaH2PO4, 0.33, KCl 5.0, MgCl2 1.0, glucose 10, HEPES 10, CaCl2 2.0. The pH was 
adjusted to 7.3 with NaOH.  Fluo-3 AM was excited at 488 nm and the emission was detected 
at 506 nm. Ca2+i concentration ([Ca2+]i) in human cardiac fibroblasts was monitored using a 
confocal scanning microscope (Olympus FV300; Tokyo, Japan) at room temperature (22-24 
°C). [Ca2+]i was calibrated with a modified procedure as described previously (Merritt et al, 
1990).  Briefly, ionomycin 2 μM was applied in the end of the experiment to induce a maximal 
increase of  [Ca2+]i, then  a Ca2+-free bath solution with 5 mM EGTA was used to reduce the 
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[Ca2+]i to the minimum.  The free [Ca2+]i was then calculated by the equation: [Ca2+]i = Kd 
[(F-F min)/(Fmax-F)], where the Kd is the dissociation constant value of a fluorescence (Kd: 
~390 nM for fluo-3), F is the measured fluorescence value, Fmax is the fluorescence value with 
ionomycin, and Fmin is the fluorescence value with Ca2+-free bath solution containing 5 mM 
EGTA.      
Messenger RNA determination 
 The messenger RNA was examined using the reverse transcription-polymerase chain 
reaction (RT-PCR) technique as described previously (Li et al, 2006;Li et al, 2005). Briefly,   
total RNA was extracted from human cardiac fibroblasts using Trizol reagent (Invitrogen), and 
further treated with DNase I (Invitrogen) for 30 min at 37°C, then heated to 75°C for 5 min and 
finally cooled to 4°C to remove genomic DNA (Gao et al, 2007). Reverse transcription was 
performed using a RT system (Promega, Madison, WI) in a 20 µl reaction mixture. A total of 2 
µg RNA was used in the reaction, and a random hexamer primer was used for the initiation of 
cDNA synthesis. After the RT procedure, the reaction mixture (cDNA) was used for PCR.  
 PCR was performed with thermal cycling conditions of 94°C for 2 min followed by 35 
cycles at 94°C for 45 s, 55-58°C for 45 s, and 72°C for 1 min using a Promega PCR kit and 
oligonucleotide primers as shown in Table 1. This was followed by a final extension at 72°C 
(10 minutes) to ensure complete product extension. The PCR products were electrophoresed 
through 1.5% agarose gels and visualized under UV transilluminator (BioRad, Hercules, CA) 
after staining with ethidium bromide.  
Statistical analysis 
 Categorical data of the present observation were analyzed with Chi-square (χ2) test. Group 
data are expressed as means±SEM. Values of P<0.05 were considered to be statistically 
significant. 
Results 
Intracellular Ca2+ activity 
 The intracellular calcium (Ca2+i) activity was measured in human cardiac fibroblasts loaded 
with fluo-3-AM using a confocal microscopy scanning technique. The signals were recorded 
every 10 s. It was found that 29.4% of cells (221 out of 752 cells) showed spontaneous 
oscillations of Ca2+i in a standard bath solution containing 2.0 mM Ca2+ without any 
stimulation, and some cells remained quiescent without change of Ca2+i (Fig. 1A and 1B).  
Percentage of cells with Ca2+i oscillations was increased to 57.3% (55 out of 96 cells, P<0.05 vs 
FBS-free) by employing 3% FBS in the bath solution (Fig. 1C). Resting [Ca2+]i (30-80 nM), 
and frequency (0.2-0.4 oscillation/min) and amplitude (100-350 nM) of Ca2+i oscillations were 
variable from cell to cell in human cardiac fibroblasts. 
Ca2+ entry pathways 
 To determine whether the spontaneous Ca2+i oscillations are dependent on external Ca2+ 
entry, the cells were exposed to a Ca2+-free solution containing 3.0 mM EDTA. Spontaneous 
Ca2+i oscillations disappeared and the resting [Ca2+]i was reduced to the minimum (close to 0 
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nM) under Ca2+-free conditions, and recovered when Ca2+ was re-applied in the bath medium 
(Fig. 2A, n=12 cells). These results suggest that Ca2+ influx was required for Ca2+i oscillations. 
 The voltage-gated L-type Ca2+ channels play important roles in excitation-contraction 
coupling in cardiac myocytes (Bers and Guo, 2005;Grueter et al, 2007). To investigate whether 
L-type Ca2+ channels mediate the Ca2+ influx in human cardiac fibroblasts, we tested the 
effects of L-type Ca2+ channel blocker nifedipine and the L-type Ca2+ channel activator Bay 
K8644. Nifedipine (10 μM) slowed the frequency of Ca2+i oscillations (Fig. 2B) in 70.6% of 
cells (12 of 17 cells, while Bay K8644 (10 μM) increased (Fig. 2C) in 75% of cells (6 of 8 cells). 
In a few cells (n = 3), nifedipine slightly increased the duration of Ca2+i oscillations (data not 
shown).  Mean values of the frequency change of Ca2+i oscillations are illustrated in Fig. 2D. 
Nifedipine (10 μM) decreased the Ca2+i oscillation frequency from 0.303 ± 0.06 
oscillation/min of control to 0.23 ± 0.07 oscillation/min (P<0.01 vs control). Bay K8644 (10 
μM) increased Ca2+i oscillation frequency from 0.29 ± 0.07 oscillation/min to 0.35±0.08 
oscillation/min (P<0.01 vs control). However, the percentage of cells with Ca2+i oscillations 
was not changed by applying either nifedipine or Bay K8644. These results suggest that L-type 
Ca2+ channels regulate the frequency of Ca2+i oscillations, but can not initiate Ca2+i oscillations.  
  SOC entry (or capacitative Ca2+ entry) is a dominant Ca2+ entry pathway in non-excitable 
cells. To determine whether SOC Ca2+ entry mediates Ca2+ influx, the SOC entry channel 
blocker La3+ (Taylor and Broad, 1998) was tested in human cardiac fibroblasts. Fig. 3A 
displays that La3+ at 100 μM completely inhibited Ca2+i oscillations (n=20). This result 
suggests that SOC entry, as in other non-excitable cells, is likely the major mediator of Ca2+ 
influx that regulates Ca2+i oscillations in human cardiac fibroblasts. 
 The SOC entry in non-excitable cells refers to a phenomenon in which depletion of 
intracellular Ca2+ stores leads to activation of Ca2+-permeable channels on the plasma 
membrane (Putney, Jr., 2007). To test whether this is the case for human cardiac fibroblasts, we 
used thapsigargin, a specific inhibitor of sarcoplasmic-endoplasmic reticulum Ca2+ pumps 
(SERCAs) (Sagara and Inesi, 1991), which induces passive depletion of intracellular Ca2+ store 
and thereby activation of the SOC entry (Takemura et al, 1989). The cells were initially 
incubated in a nominally Ca2+-free solution for 5 min, and then exposed to the solution 
containing 1 μM thapsigargin. Thapsigargin induced a rapid increase followed by a slow 
decline of [Ca2+i], suggesting an increase of [Ca2+i] caused by depletion of the Ca2+ stores. 
Re-application of external Ca2+ produced another increase of [Ca2+i], mediated by SOC entry 
channels activated by depletion of intracellular Ca2+ stores (Fig. 3B), which was completely 
prevented (Fig. 3C) or suppressed (Fig. 3D) by 100 μM La3+. Similar results were obtained in a 
total of 48 cells with (Fig. 3D) or without spontaneous Ca2+i oscillations (Fig. 3B and 3C). 
Mobilization of intracellular Ca2+ stores  
 It is well recognized that the mobilization of intracellular Ca2+ stores in cardiac myocytes is 
mediated by RyRs (Bers and Guo, 2005;Grueter et al, 2007). To investigate whether it is the 
case for human cardiac fibroblasts, ryanodine was employed to determine whether it would 
inhibit spontaneous Ca2+i oscillations. We found that ryanodine (100 μM) had no effect on the 
spontaneous Ca2+i oscillations (Fig. 4A, n=12).  In addition, the RyRs activator caffeine at 10 
mM did not produce either Ca2+i transient or oscillations (Fig. 4B, n=12). These results suggest 
that intracellular Ca2+ mobilization is not mediated by RyRs in human cardiac fibroblasts. 
 The phospholipase C inhibitor U73122 and the IP3Rs inhibitor 2-amino-ethoxydiphenyl 
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borate (2-APB) were then tested in human cardiac fibroblasts. U73122 at 5 μM significantly 
inhibited Ca2+i oscillations (Fig. 4C, n=17).  Inhibition of IP3Rs by 30 μM 2-APB suppressed 
Ca2+i oscillations (Fig. 4D, n=16). On the other hand, the IP3Rs activator thimerosal (Bootman 
et al, 1992) (3 μM) initiated Ca2+i oscillations in cells without spontaneous Ca2+i oscillations 
(Fig. 4E). The prevalence of Ca2+ oscillations was increased to 69.8% (67 of 96 cells, P<0.01 vs 
control) with 3 μM, and to 85.7 % (12 of 14 cells, P<0.01 vs control) with 10 μM thimerosal.  
  To investigate whether the Ca2+ uptake contributes to Ca2+i oscillations, the SERCA 
inhibitor cyclopiazonic acid (Munaron et al, 2004) was tested in human cardiac fibroblasts. 
Cyclopiazonic acid (10 μM) abolished spontaneous Ca2+i oscillations (Fig. 5E), similar results 
were obtained in a total of 16 cells.  
Ca2+ extrusion system in human cardiac fibroblasts 
 Plasma membrane Ca2+ ATPase (PMCA) has been identified as a main contributor of 
intracellular Ca2+ extrusion (Kip and Strehler, 2003). To determine the effects of Ca2+ extrusion 
systems on Ca2+i activity in human cardiac fibroblasts, we tested PMCA blocker carboxyeosin 
(Sedova and Blatter, 1999) on Ca2+i oscillations. Carboxyeosin (5 μM) caused a sustained 
increase of [Ca2+]i (Fig. 5A).  Similar results were obtained in a total of 16 cells. 
 Na+-Ca2+ exchanger (NCX) of mammalian plasma membrane has emerged as another 
essential Ca2+ efflux mechanism in the maintenance of intracellular Ca2+ homeostasis 
(Berridge et al, 2003;Lytton, 2007). To examine if this system participates in Ca2+ homeostasis 
in human cardiac fibroblasts, the NCX blocker Ni2+ was applied to the bath medium. Fig. 5B 
shows that the spontaneous Ca2+i oscillations were reversibly inhibited by 2 mM Ni2+. Similar 
results were obtained in a total of 8 cells. Omission of bath Na+ (Fig. 5C) inhibited Ca2+i 
oscillations and induced a slight increase in [Ca2+]i. These results suggest that Na+-Ca2+ 
exchanger plays a role in extruding Ca2+ from the cytoplasm in human cardiac fibroblasts. 
Messenger RNA of Ca2+ signaling pathways 
 Molecular identities of Ca2+ signaling pathways were examined in human cardiac 
fibroblasts with  RT-PCR using specific primers (Table 1) for IP3Rs, RyRs, SERCAs, PMCAs, 
NCXs, or SOC entry channels-related genes, etc. Fig. 6 displays the images of mRNA 
expression for these genes.  The mRNA for IP3R1, IP3R2, IP3R3, SERCA1, SERCA2, 
SERCA3, NCX-3, PMCA1, PMCA3, PMCA4, CaV1.2, TRPC1, TRPC3, TRPC4, TRPC6, 
STIM1, Orai1, Orai2, and Orai3 were significant in human cardiac fibroblasts, whereas no 
significant mRNAs for RyRs genes were found in these cells (Fig. 6A). Figure 6B displays that 
no significant bands are observed for the positive genes detected in Fig 6A when PCR reactions 
were performed with total RNA instead of the RT products.  
 
Discussion 
 Ca2+ signals are well studied in cardiac myocytes (Bers and Guo, 2005;Grueter et al, 
2007;Wang et al, 2004). However, Ca2+ signaling pathways are not well understood in human 
cardiac fibroblasts. The present study has demonstrated for the first time that the cultured 
human cardiac fibroblasts exhibit spontaneous Ca2+i oscillations (29% cells) in physiological 
solution. Exposure of these cells to a solution containing 3% FBS induces a significant increase 
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of cell number with sustained Ca2+ oscillations (57.8% cells). The Ca2+i activity is mediated by 
multiple Ca2+ signaling pathways,  including IP3Rs, SERCAs, NCX, PMCAs and SOCs, but 
not RyRs.    
 Cytosolic Ca2+ oscillations or fluctuations caused by Ca2+ mobilizing stimuli have been 
reported in many types of non-excitable cells including oocytes (Fewtrell, 1993; Kiselyov et al, 
1998), pancreatic acinar cells (LeBeau et al, 1999; Osipchuk et al, 1990), liver cells, airway 
epithelial cells (Zhang and Sanderson, 2003) and insulin-secreting β cell (Schofl et al, 1996). In 
the present study, spontaneous Ca2+i oscillations were found to be present in cultured human 
cardiac fibroblasts. Ca2+i oscillations were dependent on Ca2+ entry (Figs. 2 and 3).  
L-type Ca2+ channel has been well characterized in mammalian cardiac myocytes from 
different species including humans (Li et al, 1999;Li and Nattel, 1997), and L-type Ca2+ 
channel participates in excitation-contraction coupling in cardiac myocytes (Bers and Guo, 
2005;Grueter et al, 2007). In the present study, we found that L-type Ca2+ channel regulated 
Ca2+i oscillations in human cardiac fibroblasts. The L-type Ca2+ channel blocker nifedipine 
reduced the frequency of Ca2+i oscillations, but could not stop Ca2+i oscillations in cardiac 
fibroblasts. On the other hand, the L-type Ca2+ channel activator Bay K8644 increased the 
frequency of Ca2+i oscillations, but could not initiate Ca2+i oscillations (Fig. 2), which suggests 
that L-type Ca2+ channel in human cardiac fibroblasts as in human preadipocytes (Hu et al, 
2009), but not like in cardiomyocytes (Bers and Guo, 2005;Grueter et al, 2007), plays a less 
effect on Ca2+i activity.  
Spontaneous Ca2+i oscillations were abolished by the SOC entry channel blocker La3+ in 
human cardiac fibroblasts (Fig. 3A). Depletion of calcium store by thapsigargin activated SOC 
entry channels (Fig. 3B), and the calcium store depletion-induced increase of Ca2+i was 
prevented or suppressed by La3+ (Fig. 3C and 3D). These results suggest that in human cardiac 
fibroblasts Ca2+i activity is likely mediated by SOC entry channels.   
  It is well known that the sarcoplasmic/endoplasmic reticulum, a specialized calcium 
storing organelle, is intimately involved in regulating Ca2+ movements within cells.  IP3Rs and 
RyRs participate in the release of Ca2+ from the sarcoplasmic/endoplasmic reticulum (Berridge 
et al, 2000; Bootman and Berridge, 1995). It is interesting to note that RyRs may not be 
involved in Ca2+i activity in human cardiac fibroblasts. First, ryanodine (100 μM) had no effect 
on Ca2+i oscillations. Second, caffeine (10 mM) did not induce Ca2+ release from calcium stores 
(Fig. 4). Third, no mRNA expression of RyRs was detected in human cardiac fibroblasts (Fig. 
6A). These are clearly different from those of cardiac myocytes (Bers and Guo, 2005;Grueter 
et al, 2007), supporting the notion that RyRs contribute to Ca2+ release in excitable cells, but 
not in non-excitable cells (Chakrabarti and Chakrabarti, 2006).  
 The spontaneous Ca2+i oscillations were inhibited by the PLC inhibitor U73122 (Fig. 4C) 
or the IP3Rs inhibitor 2-amino-ethoxydiphenyl borate (Fig. 4D). In addition, the IP3Rs 
activator thimerosal (Bootman et al, 1992) significantly increased the number of cells with 
Ca2+i oscillations (Fig. 4E). These properties are similar to those observed in mesenchymal 
stem cells from human or rat bone marrow  (Foreman et al, 2006;Kawano et al, 2002) and in 
human preadipocytes (Hu et al, 2009). In these types of cells, the spontaneous Ca2+ oscillations 
and FBS-induced Ca2+i oscillations were mediated by IP3Rs. Ca2+ is a potent regulator of 
various transcription factors (Crabtree, 2001), and Ca2+i oscillations can increase both the 
efficacy and specificity of Ca2+ regulation (Dolmetsch et al, 1998;Lewis, 2003). Mathematical 
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models have demonstrated potential dependence of Ca2+i oscillations on both mobilization of 
stored Ca2+ from the endoplasmic reticulum and Ca2+ buffering and re-release by mitochondria 
(Marhl et al, 2000;Grubelnik et al, 2001). 
 In addition, Ca2+ extrusion systems significantly modified the pattern of Ca2+i activity in 
human cardiac fibroblasts. Blockade of plasma membrane Ca2+ pumps by carboxyeosin caused 
a sustained increase of Ca2+i (Fig. 5A). Inhibition of Na+-Ca2+ exchanger with Ni2+ reversibly 
suppressed spontaneous Ca2+i oscillations (Fig. 5B), while a complete block of Na+-Ca2+ 
exchanger with removal of extracellular Na+ decreased spontaneous Ca2+i oscillations, and 
caused a slight increase of basal Ca2+i (Fig. 5D), similar to that observed in human 
preadipocytes and mesenchymal stem cells (Hu et al, 2009;Kawano et al, 2002). These results 
suggest that spontaneous Ca2+i oscillations are dependent on integrated function of these Ca2+ 
homeostasis systems.  
  In addition, the present study revealed the molecular identities of Ca2+ signaling pathways 
present in human cardiac fibroblasts. We found that mRNAs for IP3R1, IP3R2, IP3R3, 
SERCA1, SERCA2, NCX3, PMCA1, PMCA3, PMCA4, and Cav1.2 (for L-type Ca2+ channel), 
and TRPC1, TRPC4, TRPC6, STIM1, Orai1, Orai2, Orai3 (for SOC entry channels). However, 
no significant mRNAs for RyRs genes were found in human cardiac fibroblasts. The molecular 
identities correlate closely with functional activities of these Ca2+ signaling pathways. 
The molecular identities of SOC entry channels have not been confirmed. Members of 
TRPC superfamily have been suspected as the major candidates for SOCs, because of 
similarities in cation permeability and activation mechanisms (Venkatachalam et al, 2002). 
Recent experiments demonstrated that stromal interacting molecule 1 (STIM1) is likely the 
“sensor” of Ca2+ within endoplasmic reticulum Ca2+ stores, translocating in response to 
store-depletion into localized areas of endoplasmic reticulum, or “puncta” close to the plasma 
membrane (Lewis, 2007;Liou et al, 2005). The STIM1 and Orai1 (calcium release-activated 
calcium modulator 1) proteins function together to mediate the store-operated Ca2+ signaling 
pathway to recognize and transduce the store-dependent signal and mediate entry of Ca2+ 
across the plasma membrane (Hewavitharana et al, 2007;Prakriya et al, 2006;Gwack et al, 
2007). Our RT-PCR results suggest that TRPC1, 3, 4, 6, STIM 1 and Orai1, 2 and 3 (Fig. 6A) 
are likely responsible for the molecular identities of SOC Ca2+ entry channels in human cardiac 
fibroblasts.  
 Collectively, the present study demonstrated that in human cardiac fibroblasts Ca2+ activity 
is mediated by multiple Ca2+ signaling pathways, including IP3Rs, SERCAs, NCX, PMCAs 
and SOCs, but not RyRs, which is not identical to those of well-studied contractile 
cardiomyocytes. The results provide a basis for future investigations into how Ca2+ signaling 
regulates biological and physiological activity of human cardiac fibroblasts and cardiac 
remodeling under pathological conditions. 
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Fig. 1. Characteristics of Ca2+i oscillations in human cardiac fibroblasts. A. ‘Pseudo’-color 
images show changes in fluorescence intensity (i.e. Ca2+i) in cell No. 1 and cell No. 2 at time 
points a, b, c, d, as indicated in panel B.  The blue color represents the minimal [Ca2+]i (close to 
0 nM), and the red color represents the highest [Ca2+]i (>100 nM). B. Spontaneous Ca2+i 
oscillations in cell No. 1 (left panel), but not in cell No. 2 (right panel) during a 10 min 
recording. C. Ca2+i oscillations were initiated by 3% FBS in a human cardiac fibroblast without 
spontaneous Ca2+i oscillations. 
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Fig. 2. Ca2+i oscillations and extracellular Ca2+. A. Spontaneous Ca2+i oscillations disappeared 
when bath medium Ca2+ was removed, and recovered when Ca2+ was re-applied (n=22).  B.  
Nifedipine (10 μM) slowed the frequency of spontaneous Ca2+i oscillations in a representative 
cell (n=12). C. Bay K8644 (10 μM) increased the frequency of spontaneous Ca2+i oscillations 
in another cell (n=6).  D. Summarized changes of Ca2+i oscillation frequency by nifedipine and 
Bay K8644 (osc., oscillation; **P<0.01 vs control). 
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Fig. 3. Ca2+ i oscillations and store-operated Ca2+ (SOC) entry.  A. Ca2+ i oscillations were fully 
suppressed by the SOC entry channel blocker La3+ (100 μM) in a representative cell (n=20). B. 
SOC entry was activated in a representative cell by depletion of Ca2+ stores with thapsigargin 
(TG, 1 μM) and re-application of 2.0 mM Ca2+ in the bath solution in a human cardiac 
fibroblast without Ca2+ oscillations.  C. La3+ (100 μM) prevented the Ca2+ increase caused by 
reapplied external Ca2+. D. La3+ (100 μM) suppressed the Ca2+ increase caused by reapplied 
external Ca2+.  
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Fig 4: Ca2+i oscillations and Ca2+ release from calcium store. A. Ryanodine (100 μM) had no 
effect on spontaneous Ca2+i oscillations in a representative cell. B. The ryanodine receptor 
activator caffeine (10 mM) did not increase Ca2+i in human cardiac fibroblasts. C. The PLC-β 
inhibitor U-73122 (10 μM) suppressed spontaneous Ca2+i oscillations in a typical experiment. 
D. The IP3Rs inhibitor 2-aminoethoxydiphenyl borate (2-APB, 30 μM) inhibited Ca2+i 
oscillations. E. The IP3Rs activator thimerosal (3 μM) initiated Ca2+i oscillations in cells 
without spontaneous Ca2+i oscillations. F.  The SERCA inhibitor cyclopiazonic acid (CPA, 10 
μM) induced a transient increase of Ca2+i and suppressed Ca2+i oscillations. 
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Fig 5: Ca2+ extrusion system and Ca2+i oscillations. A. The plasma membrane Ca2+ pump 
(PMCA) blocker carboxyeosin (5 μM) caused a sustained elevation of [Ca2+i] in a typical 
experiment. B. The Na+-Ca2+ exchanger inhibitor Ni2+ (2 mM) reversibly inhibited Ca2+i 
oscillations. C. Suppression of Na+-Ca2+ exchanger by the removal of bath medium Na+ 
decreased Ca2+i oscillations and caused a slight increase in [Ca2+i]. 
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Fig 6. Gene expression of Ca2+ signaling pathways.  A. Images of cDNA bands of PCR 
products: IP3R1, IP3R2, IP3R3, SERCA1, SERCA2, SERCA2, NCX3, PMCA1, PMCA3, 
PMCA4, Cav1.2, TRPC1, TRPC4, TRPC6, STIM1 and Orai1, Orai2, Orai3, but not RyRs, are 
significant in human cardiac fibroblasts.  B.  No significant bands were observed for the 
positive genes detected in A when total RNA was used for PCR.  
 
 
 
 
 
